Non-invasive imaging techniques to assess myocardial perfusion.


Journal

Expert review of medical devices
ISSN: 1745-2422
Titre abrégé: Expert Rev Med Devices
Pays: England
ID NLM: 101230445

Informations de publication

Date de publication:
Nov 2020
Historique:
pubmed: 13 10 2020
medline: 16 1 2021
entrez: 12 10 2020
Statut: ppublish

Résumé

Coronary artery disease affecting myocardial perfusion continues to be the leading cause of cardiovascular morbidity and mortality worldwide. While invasive evaluation based on coronary angiography and flow measurements still is considered the reference technique for assessing myocardial perfusion, technological evolutions in noninvasive imaging techniques resulted in them playing a more important role in assessing myocardial perfusion influencing therapeutic decision-making and prognostication. Different imaging modalities are used to evaluate coronary perfusion, including echocardiography, coronary computerized tomography scan, magnetic resonance imaging, and nuclear myocardial perfusion imaging. Through a combination of different techniques, it is possible to describe coronary artery anatomy and the diameter of the epicardial vessels but more recently also of the coronary microcirculation. Quantification of myocardial perfusion is feasible both at baseline and during pharmacological or physiological stress. The objective of this state-of-the-art paper is to review the recent evolutions in imaging methods to estimate myocardial perfusion and to discuss the diagnostic strengths and limitations of the different techniques. The new ultrasound technologies and the hybrid approaches seem to be the future is these fields.

Identifiants

pubmed: 33044100
doi: 10.1080/17434440.2020.1834844
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1133-1144

Commentaires et corrections

Type : ErratumIn

Auteurs

Olivier Villemain (O)

Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto , Toronto, ON, Canada.
Translational Medicine Department, SickKids Research Institute , Toronto, ON, Canada.
Medical Biophysics Department, University of Toronto , Toronto, ON, Canada.

Jérôme Baranger (J)

Translational Medicine Department, SickKids Research Institute , Toronto, ON, Canada.

Zakaria Jalal (Z)

Department of Pediatric and Adult Congenital Cardiology, Bordeaux University Hospital (CHU) , Pessac, France.
IHU Liryc, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université , Pessac- Bordeaux, France.

Christopher Lam (C)

Department of Diagnostic Imaging, The Hospital for Sick Children , Toronto, ON, Canada.
Department of Medical Imaging, University of Toronto , Toronto, ON, Canada.

Jérémie Calais (J)

Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California Los Angeles , Los Angeles, CA, USA.
Jonsson Comprehensive Cancer Center, University of California Los Angeles , Los Angeles, CA, USA.
Physics & Biology in Medicine Interdepartmental Graduate Program, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA, USA.
Institute of Urologic Oncology, University of California Los Angeles , Los Angeles, CA, USA.

Mathieu Pernot (M)

Physics for Medicine Paris, INSERM U1273, ESPCI Paris, CNRS FRE 2031, PSL Research University , Paris, France.

Barbara Cifra (B)

Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto , Toronto, ON, Canada.

Mark K Friedberg (MK)

Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto , Toronto, ON, Canada.
Translational Medicine Department, SickKids Research Institute , Toronto, ON, Canada.

Luc Mertens (L)

Division of Cardiology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto , Toronto, ON, Canada.
Translational Medicine Department, SickKids Research Institute , Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH